Funda Meric Bernstam

Ontology type: schema:Person     

Person Info




Meric Bernstam

Publications in SciGraph latest 50 shown

  • 2019-03 OncotypeDX Recurrence Score Does Not Predict Nodal Burden in Clinically Node Negative Breast Cancer Patients in ANNALS OF SURGICAL ONCOLOGY
  • 2019 Role of PI3K/AKT/mTOR in Cancer Signaling in PREDICTIVE BIOMARKERS IN ONCOLOGY
  • 2018-12 Molecular determinants of post-mastectomy breast cancer recurrence in NPJ BREAST CANCER
  • 2018-09-28 Ductal Carcinoma In Situ: Risk Factor or Cancer in ATYPICAL BREAST PROLIFERATIVE LESIONS AND BENIGN BREAST DISEASE
  • 2018-08 Radiomics to predict immunotherapy-induced pneumonitis: proof of concept in INVESTIGATIONAL NEW DRUGS
  • 2018-08 Incidence of immune-related adverse events and its association with treatment outcomes: the MD Anderson Cancer Center experience in INVESTIGATIONAL NEW DRUGS
  • 2018-06 Phase I study of the combination of crizotinib (as a MET inhibitor) and dasatinib (as a c-SRC inhibitor) in patients with advanced cancer in INVESTIGATIONAL NEW DRUGS
  • 2018-05 Phase I study of nab-paclitaxel, gemcitabine, and bevacizumab in patients with advanced cancers in BRITISH JOURNAL OF CANCER
  • 2018-03-20 Development of a prognostic scoring system for patients with advanced cancer enrolled in immune checkpoint inhibitor phase 1 clinical trials in BRITISH JOURNAL OF CANCER
  • 2018-03-06 Targeting the PI3K pathway in cancer: are we making headway? in NATURE REVIEWS CLINICAL ONCOLOGY
  • 2018-02 HER kinase inhibition in patients with HER2- and HER3-mutant cancers in NATURE
  • 2017-12 Outcomes of patients with sarcoma enrolled in clinical trials of pazopanib combined with histone deacetylase, mTOR, Her2, or MEK inhibitors in SCIENTIFIC REPORTS
  • 2017-12 Characteristics and outcomes of patients with advanced sarcoma enrolled in early phase immunotherapy trials in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2017-12 Phase I clinical trial of combination imatinib and ipilimumab in patients with advanced malignancies in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2017-12 Selinexor (KPT-330) demonstrates anti-tumor efficacy in preclinical models of triple-negative breast cancer in BREAST CANCER RESEARCH
  • 2017-12 Nanogrid single-nucleus RNA sequencing reveals phenotypic diversity in breast cancer in NATURE COMMUNICATIONS
  • 2017-10-09 Vertical inhibition of the PI3K/Akt/mTOR pathway is synergistic in breast cancer in ONCOGENESIS
  • 2017-06 Identification of frequent somatic mutations in inflammatory breast cancer in BREAST CANCER RESEARCH AND TREATMENT
  • 2017-03 Outcomes of Sentinel Lymph Node-Positive Breast Cancer Patients Treated with Mastectomy Without Axillary Therapy in ANNALS OF SURGICAL ONCOLOGY
  • 2017-02 Incidence of infusion reactions to anti-neoplastic agents in early phase clinical trials: The MD Anderson Cancer Center experience in INVESTIGATIONAL NEW DRUGS
  • 2016-12 Novel algorithmic approach predicts tumor mutation load and correlates with immunotherapy clinical outcomes using a defined gene mutation set in BMC MEDICINE
  • 2016-12 Patient-derived xenograft (PDX) models in basic and translational breast cancer research in CANCER AND METASTASIS REVIEWS
  • 2016-12 Evaluation of Novel Targeted Therapies in Aggressive Biology Sarcoma Patients after progression from US FDA approved Therapies in SCIENTIFIC REPORTS
  • 2016-11 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2016-10 Punctuated copy number evolution and clonal stasis in triple-negative breast cancer in NATURE GENETICS
  • 2016-07 Association between new-onset hypothyroidism and clinical response in patients treated with tyrosine kinase inhibitor therapy in phase I clinical trials in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2016-06 Hotspot mutations delineating diverse mutational signatures and biological utilities across cancer types in BMC GENOMICS
  • 2016-05 Phase I dose escalation study of temsirolimus in combination with metformin in patients with advanced/refractory cancers in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2016 Combination Therapies Targeting the PI3K/AKT/mTOR Pathways in PI3K-MTOR IN CANCER AND CANCER THERAPY
  • 2016-01 A Cost Analysis of Preoperative Breast MRI Use for Patients with Invasive Lobular Cancer in ANNALS OF SURGICAL ONCOLOGY
  • 2015-12 Retreatment with anti-EGFR based therapies in metastatic colorectal cancer: impact of intervening time interval and prior anti-EGFR response in BMC CANCER
  • 2015-12 Ploidy-Seq: inferring mutational chronology by sequencing polyploid tumor subpopulations in GENOME MEDICINE
  • 2015-12 Corrigendum: A pan-cancer proteomic perspective on The Cancer Genome Atlas in NATURE COMMUNICATIONS
  • 2015-12 ClinSeK: a targeted variant characterization framework for clinical sequencing in GENOME MEDICINE
  • 2015-11 TransVar: a multilevel variant annotator for precision genomics in NATURE METHODS
  • 2015-05 Characteristics and outcomes for patients with advanced vaginal or vulvar cancer referred to a phase I clinical trials program: the MD Anderson cancer center experience in GYNECOLOGIC ONCOLOGY RESEARCH AND PRACTICE
  • 2015-02 Beyond BRAFV600: Clinical Mutation Panel Testing by Next-Generation Sequencing in Advanced Melanoma in JOURNAL OF INVESTIGATIVE DERMATOLOGY
  • 2015-01 Surgical Patterns of Care in Patients with Invasive Breast Cancer Treated with Neoadjuvant Systemic Therapy and Breast Magnetic Resonance Imaging: Results of a Secondary Analysis of TBCRC 017 in ANNALS OF SURGICAL ONCOLOGY
  • 2014-12 A pan-cancer proteomic perspective on The Cancer Genome Atlas in NATURE COMMUNICATIONS
  • 2014-12 Next generation sequencing analysis of platinum refractory advanced germ cell tumor sensitive to Sunitinib (Sutent®) a VEGFR2/PDGFRβ/c-kit/ FLT3/RET/CSF1R inhibitor in a phase II trial in JOURNAL OF HEMATOLOGY & ONCOLOGY
  • 2014-12 Activated autologous dendritic cells injected intratumorally are able to overcome local and systemic immune suppression imposed by the tumor and its microenvironment in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2014-08 Clonal evolution in breast cancer revealed by single nucleus genome sequencing in NATURE
  • 2014-01 Impact of Identification of Internal Mammary Sentinel Lymph Node Metastasis in Breast Cancer Patients in ANNALS OF SURGICAL ONCOLOGY
  • 2013-12 Radiation dose escalation for loco-regional recurrence of breast cancer after mastectomy in RADIATION ONCOLOGY
  • 2013-12 Incidence and Consequence of Close Margins in Patients with Ductal Carcinoma-In Situ Treated with Mastectomy: Is Further Therapy Warranted? in ANNALS OF SURGICAL ONCOLOGY
  • 2013-06 Primary Tumor Extirpation in Breast Cancer Patients Who Present with Stage IV Disease is Associated with Improved Survival in ANNALS OF SURGICAL ONCOLOGY
  • 2013-05 Other Primary Malignancies in Breast Cancer Patients Treated with Breast Conserving Surgery and Radiation Therapy in ANNALS OF SURGICAL ONCOLOGY
  • 2013-01 High stearoyl-CoA desaturase 1 expression is associated with shorter survival in breast cancer patients in BREAST CANCER RESEARCH AND TREATMENT
  • 2012-11 Biology, Treatment, and Outcome in Very Young and Older Women with DCIS in ANNALS OF SURGICAL ONCOLOGY
  • 2012-10 Aberrations in translational regulation are associated with poor prognosis in hormone receptor-positive breast cancer in BREAST CANCER RESEARCH
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

        "@context": "", 
        "affiliation": [
            "affiliation": {
              "id": "", 
              "type": "Organization"
            "isCurrent": true, 
            "type": "OrganizationRole"
            "id": "", 
            "type": "Organization"
            "id": "", 
            "type": "Organization"
            "id": "", 
            "type": "Organization"
            "id": "", 
            "type": "Organization"
            "id": "", 
            "type": "Organization"
            "id": "", 
            "type": "Organization"
            "id": "", 
            "type": "Organization"
            "id": "", 
            "type": "Organization"
            "id": "", 
            "type": "Organization"
        "familyName": "Meric Bernstam", 
        "givenName": "Funda", 
        "id": "sg:person.01065126442.79", 
        "sameAs": [
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T14:42", 
        "sdLicense": "", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_453.json", 
        "type": "Person"

    Download the RDF metadata as:  json-ld nt turtle xml License info


    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' ''

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' ''

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' ''

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' ''


    This table displays all metadata directly associated to this object as RDF triples.

    34 TRIPLES      10 PREDICATES      20 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.01065126442.79 schema:affiliation N4ae77b4a5e9b4410944bc437b0b4a94d
    11 schema:familyName Meric Bernstam
    12 schema:givenName Funda
    13 schema:sameAs
    14 schema:sdDatePublished 2019-03-07T14:42
    15 schema:sdLicense
    16 schema:sdPublisher N326baffb04e14332a2039fde0778efb9
    17 sgo:license sg:explorer/license/
    18 sgo:sdDataset persons
    19 rdf:type schema:Person
    20 N326baffb04e14332a2039fde0778efb9 schema:name Springer Nature - SN SciGraph project
    21 rdf:type schema:Organization
    22 N4ae77b4a5e9b4410944bc437b0b4a94d schema:affiliation
    23 sgo:isCurrent true
    24 rdf:type schema:OrganizationRole
    25 schema:Organization
    26 schema:Organization
    27 schema:Organization
    28 schema:Organization
    29 schema:Organization
    30 schema:Organization
    31 schema:Organization
    32 schema:Organization
    33 schema:Organization
    34 schema:Organization

    Preview window. Press ESC to close (or click here)